Dr. Matthew Dallos, MD
Claim this profileColumbia University Medical Center (Cumc)
Affiliated Hospitals
Columbia University Irving Medical Center
Columbia University
Clinical Trials Matthew Dallos, MD is currently running
2141-V11 Antibody
for Prostate Cancer
The purpose of this study is to see whether combining 2141-V11 with various standard treatments is an effective treatment approach for prostate cancer. 2141-V11 works by activating the immune system to find and kill cancer cells. Researchers will look at whether this treatment approach is able to completely get rid of cancer in participants, and they will check for the presence of minimal residual disease (MRD) in participants. MRD is a small number of cancer cells that can be detected in the body after treatment.
Recruiting
1 award
Phase 2
Pembrolizumab + AR Inhibitors
for Prostate Cancer
This is a phase I/II study investigating the combination of 225Ac-J591 (a drug that can deliver radiation to prostate cancer cells) with pembrolizumab (immunotherapy, a drug that increases the immune system's ability to destroy cancer cells). This study will assess whether 225Ac-J591 + pembrolizumab + androgen receptor inhibitor (ARI) is more effective against prostate cancer than pembrolizumab + ARI alone.
Recruiting
2 awards
Phase 1 & 2
9 criteria
More about Matthew Dallos, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Matthew Dallos, MD has experience with
- BMS-986253
- Nivolumab
- Degarelix
- 2141-V11
- Abiraterone Acetate
- Apalutamide
Breakdown of trials Matthew Dallos, MD has run
Prostate Cancer
Cancer
Renal Cell Carcinoma
I Am A Healthy Volunteer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Dallos, MD specialize in?
Matthew Dallos, MD focuses on Prostate Cancer and Cancer. In particular, much of their work with Prostate Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Matthew Dallos, MD currently recruiting for clinical trials?
Yes, Matthew Dallos, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Matthew Dallos, MD has studied deeply?
Yes, Matthew Dallos, MD has studied treatments such as BMS-986253, Nivolumab, Degarelix.
What is the best way to schedule an appointment with Matthew Dallos, MD?
Apply for one of the trials that Matthew Dallos, MD is conducting.
What is the office address of Matthew Dallos, MD?
The office of Matthew Dallos, MD is located at: Columbia University Medical Center (Cumc), New York, New York 10032 United States. This is the address for their practice at the Columbia University Medical Center (Cumc).
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.